Decreasing median age of COVID-19 cases in the United States-Changing epidemiology or changing surveillance?

PLoS One. 2020 Oct 15;15(10):e0240783. doi: 10.1371/journal.pone.0240783. eCollection 2020.

Abstract

Background: Understanding and monitoring the demographics of SARS-CoV-2 infection can inform strategies for prevention. Surveillance monitoring has suggested that the age distribution of people infected with SARS-CoV-2 has changed since the pandemic began, but no formal analysis has been performed.

Methods: Retrospective review of SARS-CoV-2 molecular testing results from a national reference laboratory was performed. Result distributions by age and positivity were compared between early period (March-April 2020) and late periods (June-July 2020) of the COVID-19 pandemic. Additionally, a sub-analysis compared changing age distributions between inpatients and outpatients.

Results: There were 277,601 test results of which 19320 (7.0%) were positive. The median age of infected people declined over time (p < 0.0005). In March-April, the median age of positive people was 40.8 years (Interquartile range (IQR): 29.0-54.1). In June-July, the median age of positive people was 35.8 years (IQR: 24.0-50.2). The positivity rate of patients under 50 increased from 6.0 to 10.6 percent and the positivity rate for those over 50 decreased from 6.3 to 5.0 percent between the early and late periods. The trend was only observed for outpatient populations.

Conclusions: We confirm that there is a trend toward decreasing age among persons with laboratory-confirmed SARS-CoV-2 infection, but that these trends seem to be specific to the outpatient population. Overall, this suggests that observed age-related trends are driven by changes in testing patterns rather than true changes in the epidemiology of SARS-CoV-2 infection. This calls for caution in interpretation of routine surveillance data until testing patterns stabilize.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Age Distribution
  • Aged
  • Aged, 80 and over
  • COVID-19
  • COVID-19 Testing
  • Child
  • Child, Preschool
  • Clinical Laboratory Techniques / standards
  • Clinical Laboratory Techniques / statistics & numerical data*
  • Coronavirus Infections / diagnosis
  • Coronavirus Infections / epidemiology*
  • Epidemiological Monitoring*
  • Humans
  • Infant
  • Middle Aged
  • Pandemics
  • Pneumonia, Viral / epidemiology*
  • United States

Grants and funding

This work was supported by internal funds at Kaiser Permanente Washington (MLJ, DG). No specific funding was provided to (RLS, JCD, DRH). The funder provided support in the form of salaries for authors [MLJ, DG], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the ‘author contributions’ section.